GlassScriptPhysician profile
Matt T Rosenberg
NPI 1730289711
$550,107.20
in general payments reported to CMS, 2019-2025
67 companies · $67K in 2025
The $67K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $13K · 2021: $34K · 2022: $113K · 2023: $142K · 2024: $100K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $177K · Consulting Fee: $80K · Travel and Lodging: $40K · Food and Beverage: $9,589 · Honoraria: $1,500 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $176,604.98 |
| Consulting Fee | $80,305.71 |
| Travel and Lodging | $40,433.32 |
| Food and Beverage | $9,589.27 |
| Honoraria | $1,500.00 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $210,416.88 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $112,807.24 | 2019-2025 | Veozah |
| Urovant Sciences INC | $88,792.71 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $44,131.36 | 2019-2020 | |
| Opko Pharmaceuticals, LLC | $29,000.00 | 2023-2024 | Rayaldee |
| Ferring Pharmaceuticals As | $20,191.50 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $12,189.98 | 2020-2022 | |
| Boston Scientific Corporation | $10,637.09 | 2019-2020 | |
| Acerus Pharmaceuticals Corporation | $7,594.63 | 2022 | |
| Novo Nordisk INC | $2,292.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Topcon Healthcare, INC. | $1,500.00 | 2025 | |
| Amgen INC. | $1,302.89 | 2019-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $1,228.05 | 2019-2025 | |
| Abbvie INC. | $956.49 | 2019-2025 | Vraylar, Ubrelvy, Viberzi |
| Glaxosmithkline, LLC. | $617.89 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $604.77 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $598.80 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $435.23 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Merck Sharp & Dohme LLC | $379.60 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $352.98 | 2021-2025 | Jardiance, Ofev |
| Novartis Pharmaceuticals Corporation | $299.07 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $291.96 | 2019-2023 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $260.91 | 2019-2025 | Austedo Xr, Austedo Xr |
| Tris Pharma INC | $255.62 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $228.37 | 2024 | Qelbree, Xyosted |
| Kowa Pharmaceuticals America, INC. | $204.40 | 2019-2023 | Livalo, Seglentis |
| Allergan, INC. | $203.33 | 2019-2020 | |
| Amarin Pharma, INC. | $173.39 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.39 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $144.16 | 2019-2024 | Trintellix |
| Digital Diagnostics INC. | $131.44 | 2024 | Lumineticscore |
| Collegium Pharmaceutical, INC. | $127.57 | 2019-2025 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.27 | 2020-2022 | |
| Axsome Therapeutics, INC. | $115.69 | 2022-2025 | Sunosi, Auvelity |
| Exact Sciences Corporation | $111.63 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Aimmune Therapeutics, INC. | $96.33 | 2024-2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $92.92 | 2021-2023 | |
| Eisai INC. | $84.67 | 2020-2025 | |
| Dexcom, INC. | $74.71 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $73.94 | 2020-2024 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $73.71 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Horizon Therapeutics Plc | $64.67 | 2019-2021 | |
| Baxter Healthcare | $61.88 | 2022 | |
| Averitas Pharma INC. | $59.84 | 2023-2024 | Qutenza |
| Corcept Therapeutics | $50.07 | 2025 | Korlym |
| Almatica Pharma LLC | $49.88 | 2021 | |
| Inspire Medical Systems, INC. | $43.44 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $40.68 | 2019-2025 | |
| Esperion Therapeutics, INC. | $37.97 | 2024-2025 | Nexletol |
| Phathom Pharmaceuticals, INC. | $36.32 | 2024 | Voquezna |
| Olympus America INC. | $35.34 | 2025 | Itind System |
| Ironshore Pharmaceuticals INC. | $29.21 | 2019 | |
| Medtronic, INC. | $25.93 | 2021 | |
| Sage Therapeutics, LLC | $22.81 | 2025 | Zurzuvae |
| Agios Pharmaceuticals, INC. | $21.54 | 2022 | |
| Halozyme INC | $18.78 | 2023 | |
| Alexion Pharmaceuticals, INC. | $18.24 | 2024 | Strensiq |
| Sanofi Pasteur INC. | $17.75 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.87 | 2022 | |
| Seqirus USA INC | $16.42 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.01 | 2023 | Quviviq |
| Circassia INC. | $14.35 | 2019 | |
| Baudax Bio INC. | $14.29 | 2020 | |
| Jazz Pharmaceuticals INC. | $13.92 | 2020 | |
| Ibsa Pharma INC. | $13.41 | 2021 | |
| Intercept Pharmaceuticals, INC. | $13.17 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matt Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.